Multicomponent drug efflux complexes: Architecture and mechanism of assembly

Future Microbiology

Volumn 4, Issue 7, 2009, Pages 919-932

  Zgurskaya, Helen I ^a  

^a UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

Antibiotic resistance; Membrane fusion protein; Multidrug efflux transporter; TolC

Indexed keywords

ABC TRANSPORTER; ACRAB TOLC PROTEIN; BACTERIAL PROTEIN; BETA LACTAM ANTIBIOTIC; CARRIER PROTEIN; ESCHERICHIA COLI PROTEIN; MACA PROTEIN; MACB PROTEIN; MAJOR FACILITATOR SUPERFAMILY PROTEIN; MEMBRANE FUSION PROTEIN; MULTIDRUG RESISTANCE PROTEIN; MULTIPROTEIN COMPLEX; PROTEIN EMRA; RESISTANCE NODULATION CELL DIVISION PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; BACTERIAL OUTER MEMBRANE; CELL MEMBRANE TRANSPORT; CHANNEL GATING; COMPLEX FORMATION; DRUG TRANSPORT; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; MOLECULAR MECHANICS; NONHUMAN; NUCLEOTIDE BINDING SITE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN STRUCTURE; REVIEW; SITE DIRECTED MUTAGENESIS; STRUCTURAL HOMOLOGY; TRANSPORT KINETICS;

ANTI-BACTERIAL AGENTS; BIOLOGICAL TRANSPORT, ACTIVE; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; MACROMOLECULAR SUBSTANCES; MEMBRANE TRANSPORT PROTEINS; MODELS, BIOLOGICAL; MODELS, CHEMICAL;

NEGIBACTERIA;

EID: 70349218869     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/fmb.09.62     Document Type: Review

References (111)

1. Levy SB, Marshall B: Antibacterial resistance worldwide: causes, challenges and responses. Nat. Med. 10, S122-S129 (2004).
2. Livermore DM: The need for new antibiotics. Clin. Microbiol. Infect. 10(Suppl. 4), 1-9 (2004).
3. Nikaido H, Vaara M: Molecular basis of bacterial outer membrane permeability. Microbiol. Rev. 49, 1-32 (1985).
4. Lomovskaya O, Lewis K: Emr, an Escherichia coli locus for multidrug resistance. Proc. Natl Acad. Sci. USA 89, 8938-8942 (1992).
5. Ma D, Cook DN, Alberti M et al.: Molecular cloning and characterization of acrA and acrE genes of Escherichia coli. J. Bacteriol. 175, 6299-6313 (1993).
6. Lomovskaya O, Zgurskaya HI, Totrov M, Watkins WJ: Waltzing transporters and 'the dance macabre' between humans and bacteria. Nat. Rev. Drug Discov. 6, 56-65 (2007).
7. Nikaido H: Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria. Semin. Cell Dev. Biol. 12, 215-223 (2001).
8. Zgurskaya HI, Krishnamoorthy G, Tikhonova EB, Lau SY, Stratton KL: Mechanism of antibiotic efflux in Gram-negative bacteria. Front. Biosci. 8, s862-s873 (2003).
9. Dinh T, Paulsen IT, Saier MH Jr: A family of extracytoplasmic proteins that allow transport of large molecules across the outer membranes of Gram-negative bacteria. J. Bacteriol. 176, 3825-3831 (1994).
10. Aires JR, Nikaido H: Aminoglycosides are captured from both periplasm and cytoplasm by the AcrD multidrug efflux transporter of Escherichia coli. J. Bacteriol. 187, 1923-1929 (2005).
11. Tikhonova EB, Devroy VK, Lau SY, Zgurskaya HI. Reconstitution of the Escherichia coli macrolide transporter: the periplasmic membrane fusion protein MacA stimulates the ATPase activity of MacB. Mol. Microbiol. 63, 895-910 (2007).
12. Zgurskaya HI, Nikaido H: Bypassing the periplasm: reconstitution of the AcrAB multidrug efflux pump of Escherichia coli. Proc. Natl Acad. Sci. USA 96, 7190-7195 (1999).
13. Andersen C, Hughes C, Koronakis V: Protein export and drug efflux through bacterial channel-tunnels. Curr. Opin. Cell Biol. 13, 412-416 (2001).
14. Thanabalu T, Koronakis E, Hughes C, Koronakis V: Substrate-induced assembly of a contiguous channel for protein export from E. coli: reversible bridging of an inner-membrane translocase to an outer membrane exit pore. EMBO J. 17, 6487-6496 (1998).
15. Paulsen IT, Chen J, Nelson KE, Saier MH Jr: Comparative genomics of microbial drug efflux systems. J. Mol. Microbiol. Biotechnol. 3, 145-150 (2001).
16. Saier MH Jr, Beatty JT, Goffeau A et al.: The major facilitator superfamily. J. Mol. Microbiol. Biotechnol. 1, 257-279 (1999).
17. Tseng TT, Gratwick KS, Kollman J et al.: The RND permease superfamily: an ancient, ubiquitous and diverse family that includes human disease and development proteins. J. Mol. Microbiol. Biotechnol. 1, 107-125 (1999).
18. Saier MH Jr, Paulsen IT, Sliwinski MK et al.: Evolutionary origins of multidrug and drug-specific efflux pumps in bacteria. FASEB J. 12, 265-274 (1998).
19. Poole K: Efflux-mediated multiresistance in Gram-negative bacteria. Clin. Microbiol. Infect. 10, 12-26 (2004).
20. Sobel ML, Hocquet D, Cao L, Plesiat P, Poole K: Mutations in PA3574 ( nalD) lead to increased MexAB-OprM expression and multidrug resistance in laboratory and clinical isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 49, 1782-1786 (2005).
21. Zgurskaya HI, Nikaido H: Multidrug resistance mechanisms: drug efflux across two membranes. Mol. Microbiol. 37, 219-225 (2000).
22. Nikaido H, Zgurskaya HI: AcrAB and related multidrug efflux pumps of Escherichia coli. J. Mol. Microbiol. Biotechnol. 3, 215-218 (2001).
23. Koronakis V, Sharff A, Koronakis E, Luisi B, Hughes C: Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export. Nature 405, 914-919 (2000).
24. Mikolosko J, Bobyk K, Zgurskaya HI, Ghosh P: Conformational flexibility in the multidrug efflux system protein AcrA. Structure 14, 577-587 (2006).
25. Murakami S, Nakashima R, Yamashita E, Yamaguchi A: Crystal structure of bacterial multidrug efflux transporter AcrB. Nature 419, 587-593 (2002).
26. Akama H, Kanemaki M, Yoshimura M et al.: Crystal structure of the drug discharge outer membrane protein, OprM, of Pseudomonas aeruginosa: dual modes of membrane anchoring and occluded cavity end. J. Biol. Chem. 279, 52816-52819 (2004).
27. Akama H, Matsuura T, Kashiwagi S et al.: Crystal structure of the membrane fusion protein, MexA, of the multidrug transporter in Pseudomonas aeruginosa. J. Biol. Chem. 279, 25939-25942 (2004).
28. Sennhauser G, Bukowska MA, Briand C, Grutter MG: Crystal structure of the multidrug exporter MexB from Pseudomonas aeruginosa. J. Mol. Biol. 389, 134-145 (2009).
29. Murakami S, Nakashima R, Yamashita E, Matsumoto T, Yamaguchi A: Crystal structures of a multidrug transporter reveal a functionally rotating mechanism. Nature 443, 173-179 (2006).
30. YU EW, Aires JR, McDermoft G, Nikaido H: A periplasmic drug-binding site of the AcrB multidrug efflux pump: a crystallographic and site-directed mutagenesis study. J. Bacteriol. 187, 6804-6815 (2005).
31. Yu EW, McDermott G, Zgurskaya HI, Nikaido H, Koshland DE Jr: Structural basis of multiple drug-binding capacity of the AcrB multidrug efflux pump. Science 300, 976-980 (2003).
32. Seeger MA, Schiefner A, Eicher T et al.: Structural asymmetry of AcrB trimer suggests a peristaltic pump mechanism. Science 313, 1295-1298 (2006).
33. Murakami S: Multidrug efflux transporter, AcrB - the pumping mechanism. Curr. Opin. Struct. Biol. 18, 459-465 (2008).
34. Nikaido H, Takatsuka Y. Mechanisms of RND multidrug efflux pumps. Biochim. Biophys. Acta 1794, 769-781 (2009).
35. Pos KM: Drug-transport mechanism of the AcrB efflux pump. Biochim. Biophys. Acta 1794, 782-773 (2009).
36. Seeger MA, von Ballmoos C, Eicher T et al.: Engineered disulfide bonds support the functional rotation mechanism of multidrug efflux pump AcrB. Nat. Struct. Mol. Biol. 15, 199-205 (2008).
37. Takatsuka Y, Nikaido H: Site-directed disulfide crosslinking shows that cleft flexibility in the periplasmic domain is needed for the multidrug efflux pump AcrB of Escherichia coli. J. Bacteriol. 189, 8677-8684 (2007).
38. Su CC, Li M, Gu R et al.: Conformation of the AcrB multidrug efflux pump in mutants of the putative proton relay pathway. J. Bacteriol. 188, 7290-7296 (2006).
39. Tikhonova EB, Zgurskaya HI: AcrA, AcrB, and TolC of Escherichia coli form a stable intermembrame multidrug efflux complex. J. Biol. Chem. 279, 32116-32124 (2004).
40. Takatsuka Y, Nikaido H: Covalently linked trimer of the AcrB multidrug efflux pump provides support for the functional rotating mechanism: J. Bacteriol. 191, 1729-1737 (2009).
41. Nagano K, Nikaido H: Kinetic behavior of the major multidrug efflux pump AcrB of Escherichia coli. Proc. Natl Acad. Sci. USA 106, 5854-5858 (2009).
42. Federici L, Du D, Walas F et al.: The crystal structure of the outer membrane protein VceC from the bacterial pathogen Vibrio cholerae at 1.8 Å resolution. J. Biol. Chem. 280, 15307-15314 (2005).
43. Andersen C, Koronakis E, Bokma E et al.: Transition to the open state of the TolC periplasmic tunnel entrance. Proc. Natl Acad. Sci. USA 99, 11103-11108 (2002).
44. Bavro VN, Pietras Z, Furnham N et al.: Assembly and channel opening in a bacterial drug efflux machine. Mol. Cell 30, 114-121 (2008).
45. Touze T, Eswaran J, Bokma F et al.: Interactions underlying assembly of the Escherichia coli AcrAB-TolC multidrug efflux system. Mol. Microbiol. 53, 697-706 (2004).
46. Borges-Walmsley MI, Beanchamp J, Kelly SM et al.: Identification of oligomerization and drug-binding domains of the membrane fusion protein EmrA. J. Biol. Chem. 278, 12903-12912 (2003).
47. Pimenta AL, Racher K, Jamieson L, Blight MA, Holland IB: Mutations in HlyD, part of the type 1 translocator for hemolysin secretion, affect the folding of the secreted toxin. J. Bacteriol. 187, 7471-7480 (2005).
48. Bagai I, Liu W, Rensing C, Blackburn NJ, McEvoy MM: Substrate-linked conformational change in the periplasmic component of a Cu(I)/Ag(I) efflux system. J. Biol. Chem. 282, 35695-35702 (2007).
49. Zgurskaya HI, Yamada Y, Tikhonova EB, Ge Q, Krishnamoorthy G: Structural and functional diversity of bacterial membrane fusion proteins. Biochim. Biophys. Acta 1794, 794-807 (2009).
50. Symmons MF, Bokina E, Koronakis E, Hughes C, Koronakis V: The assembled structure of a complete tripartite bacterial multidrug efflux pump. Proc. Natl Acad. Sci. USA 106, 7173-7178 (2009).
51. Krishnamoorthy G, Tikhonova EB, Zgurskaya HI: Fitting periplasmic membrane fusion proteins to inner membrane transporters: mutations that enable Escherichia coli AcrA to function with Pseudomonas aeruginosa MexB. J. Bacteriol. 190, 691-698 (2008).
52. Lobedanz S, Bokma E, Symmons MF et al.: A periplasmic coiled-coil interface underlying TolC recruitment and the assembly of bacterial drug efflux pumps. Proc. Natl Acad. Sci. USA 104, 4612-4617 (2007).
53. Ip H, Stratton K, Zgurskaya H, Liu J: pH-induced conformational changes of AcrA, the membrane fusion protein of Escherichia coli multidrug efflux system. J. Biol. Chem. 278, 50474-50482 (2003).
54. Ge Q, Yamada Y, Zgurskaya H: The C-terminal domain of AcrA is essential for the assembly and function of the multidrug efflux pump AcrAB-TolC. J. Bacteriol. 191, 4365-4371 (2009).
55. Misra R, Bavro VN: Assembly and transport-mechanism of tripartite drug efflux systems. Biochim. Biophys. Acta 1794, 817-825 (2009).
56. Reffay M, Gambio Y, Benabdelhak H et al.: Tracking membrane protein association in model membranes. PLos One 4, e5035 (2009).
57. Davis DR, McAlpine JB, Pazoles CJ et al.: Enterococcus faecalis multi-drug resistance transporters: application for anntibiotic discovery. J. Mol. Microbiol. Biotechnol. 3, 179-184 (2001).
58. Paulsen IT, Park JH, Choi PS, Saier MH Jr: A family of Gram-negative bacterial outer membrane factors that function in the export of proteins, carbohydrates, drugs and heavy metals from Gram-negative bacteria. FEMS Microbiol. Lett. 156, 1-8 (1997).
59. Davidson AL, Dassa E, Orelle C, Chen J: Structure, function, and evolution of bacterial ATP-binding cassette systems. Microbiol. Mol. Biol. Rev. 72, 317-364 (2008).
60. Seeger MA, van Veen HW: Molecular basis of multidrug transport by ABC transporters. Biochim. Biophys. Acta 1794, 725-737 (2009).
61. Locher KP: Review. Structure and mechanism of ATP-binding cassette transporters. Philos. Trans. R. Soc. Lond. B Biol. Sci. 364, 239-245 (2009).
62. Kobayashi N, Nishino K, Hirata T, Yamaguchi A: Membrane topology of ABC-type macrolide antibiotic exporter MacB in Escherichia coli. FEBS Lett. 546, 241-246 (2003).
63. Xu Y, Sim SH, Nam KH et al.: Crystal structure of the periplasmic region of MacB, a noncanonic ABC transporter. Biochemistry 48, 5218-5225 (2009).
64. Aller SG, Yu J, Ward A et al.: Structure of P-glycoprotein reveals a molecular basis for poly specific drug binding. Science 323, 1718-1722 (2009).
65. Dawson RJ, Locher KP: Structure of a bacterial multidrug ABC transporter. Nature, 443, 180-185 (2006).
66. Reyes CL, Chang G: Structure of the ABC transporter MsbA in complex with ADP.vanadate and lipopolysaccharide. Science 308, 1028-1031 (2005).
67. Rosenberg MF, Mao Q, Holzenburg A et al.: The structure of the multidrug resistance protein 1 (MRP1/ABCC1) crystallization and single-particle analysis. J. Biol. Chem. 276, 16076-16082 (2001).
68. Pleban K, Kopp S, Csaszar E et al.: P-glycoprotein substrate binding domains are located at the transmembrane domain/transmembrane domain interfaces: a combined photoaffinity labeling-protein homology modeling approach. Mol. Pharmacol. 67, 365-374 (2005).
69. Reyes CL, Ward, A, Yu J, Chang G: The structures of MsbA: insight into ABC transporter-mediated multidrug efflux. FEBS Lett. 580, 1042-1048 (2006).
70. Higgins CF, Linton KJ: The ATP switch model for ABC transporters. Nat. Struct. Mol. Biol. 11, 918-926 (2004).
71. Senior AE: Catalytic mechanism of P-glycoprotein, Acta Physiol. Scand. Suppl. 643, 213-218 (1998).
72. Hollenstein K, Dawson RJ, Locher KP: Structure and mechanism of ABC transporter proteins. Curr. Opin. Struct. Biol. 17, 412-418 (2007).
73. Oldham ML, Davidson AL, Chen J: Structural insights into ABC transporter mechanism. Curr. Opin. Struct. Biol. 18, 726-733 (2008).
74. Holland IB, Blight MA, Kenny B: The mechanism of secretion of hemolysin and other polypeptides from Gram-negative bacteria. J. Bioenerg. Biomembr. 22, 473-491 (1990).
75. Delepelaire P: PrtD, the integral membrane ATP-binding cassette component of the Erwinia chrysanthemi metalloprotease secretion system, exhibits a secretion signal-regulated ATPase activity. J. Biol. Chem. 269, 27952-27957 (1994).
76. Gilson L, Mahanty HK, Kolter R: Genetic analysis of an MDR-like export system: the secretion of colicin V. EMBO J. 9, 3875-3894 (1990).
77. Kobayashi N, Nishino K, Yamaguchi A: Novel macrolide-specific ABC-type efflux transporter in Escherichia coli. J. Bacteriol. 183, 5639-5644 (2001).
78. Yamanaka H, Kobayashi H, Takahashi E, Okamoto K: MacAB is involved in the secretion of Escherichia coli heat-stable enterotoxin II. J. Bacteriol. 190, 7693-7698 (2008).
79. Dubern JF, Coppoolse ER, Stiekema WJ, Bloemberg GV: Genetic and functional characterization of the gene cluster directing the biosynthesis of putisolvin I and II in Pseudomonas putida strain PCL1445. Microbiology 154, 2070-2083 (2008).
80. Johnson JM, Church GM: Alignment and structure prediction of divergent protein families: periplasmic and outer membrane proteins of bacterial efflux pumps. J. Mol. Biol. 287, 695-715 (1999).
81. Balakrishnan L, Hughes C, Koronakis V: Substrate-triggered recruitment of the TolC channel-tunnel during type I export of hemolysin by Escherichia coli. J. Mol. Biol. 313, 501-510 (2001).
82. Yum S, Xu Y, Piao S et al.: Crystal structure of the periplasmic component of a tripartite macrolide-specific efflux pump. J. Mol. Biol. 387, 1286-1297 (2009).
83. Lin HT, Bavro VN, Barrera NP et al.: MacB ABC transporter is a dimer whose ATPase activity and macrolide-binding capacity are regulated by the membrane fusion protein MacA. J. Biol. Chem. 284, 1145-1154 (2009).
84. Nikaido H, Hall JA: Overview of bacterial ABC transporters. Methods Enzymol. 292, 3-20 (1998).
85. Yu EW, Aires JR, Nikaido H: AcrB multidrug efflux pump of Escherichia coli: composite substrate-binding cavity of exceptional flexibility generates its extremely wide substrate specificity. J. Bacteriol. 185, 5657-5664 (2003).
86. Tikhonova EB, Wang Q, Zgurskaya HI: Chimeric analysis of the multicomponent multidrug efflux transporters from Gram-negative bacteria. J. Bacteriol. 184, 6499-6507 (2002).
87. Nehme D, Li XZ, Elliot R, Poole K: Assembly of the MexAB-OprM multidrug efflux system of Pseudomonas aeruginosa: identification and characterization of mutations in mexA compromising MexA multimerization and interaction with MexB. J. Bacteriol. 186, 2973-2983 (2004).
88. Mao W, Warren MS, Black DS et al.: On the mechanism of substrate specificity by resistance nodulation division (RND)-type multidrug resistance pumps: the large periplasmic loops of MexD from Pseudomonas aeruginosa are involved in substrate recognition. Mol. Microbiol. 46, 889-901 (2002).
89. Elkins CA, Nikaido H: Substrate specificity of the RND-type multidrug efflux pumps AcrB and AcrD of Escherichia coli is determined predominately by two large periplasmic loops. J. Bacteriol. 184, 6490-6498 (2002).
90. Middlemiss JK, Poole K: Differential impact of MexB mutations on substrate selectivity of the MexAB-OprM multidrug efflux pump of Pseudomonas aeruginosa. J. Bacteriol. 186, 1258-1269 (2004).
91. Paulsen IT, Brown MH, Skurray RA: Characterization of the earliest known Staphylococcus aureus plasmid encoding a multidrug efflux system. J. Bacteriol. 180, 3477-3479 (1998).
92. Brown MH, Skurray RA: Staphylococcal multidrug efflux protein QacA. J. Mol. Microbiol. Biotechnol. 3, 163-170 (2001).
93. Bolhuis H, Poelarends G, van Veen HW et al.: The lactococcal lmrP gene encodes a proton motive force-dependent drug transporter. J. Biol Chem. 270, 26092-26098 (1995).
94. Neyfakh AA: The multidrug efflux transporter of Bacillus subtilis is a structural and functional homolog of the Staphylococcus NorA protein. Antimicrob. Agents Chemother. 36, 484-485 (1992).
95. Lewinson O, Adler J, Poelarends GJ et al.: The Escherichia coli multidrug transporter MdfA catalyzes both electrogenic and electroneutral transport reactions. Proc. Natl Acad. Sci. USA 100, 1667-1672 (2003).
96. Abramson J, Smirnova I, Kasho V et al.: Structure and mechanism of the lactose permease of Escherichia coli. Science 301, 610-615 (2003).
97. Yin Y, He X, Szewczyk P, Nguyen T, Chang G: Structure of the multidrug transporter EmrD from Escherichia coli. Science 312, 741-744 (2006).
98. Lemieux MJ, Huang Y, Wang DN: The structural basis of substrate translocation by the Escherichia coli glycerol-3-phosphate transporter: a member of the major facilitator superfamily. Curr. Opin. Struct. Biol. 14, 405-412 (2004).
99. Fluman N, Bibi E: Bacterial multidrug transport through the lens of the major facilitator superfamily. Biochim. Biophys. Acta 1794, 738-747 (2009).
100. Saidijam M, Benedetti G, Ren Q et al.: Microbial drug efflux proteins of the major facilitator superfamily. Curr. Drug Targets 7, 793-811 (2006).
101. Smirnova I, Kasho V, Choe JY et al.: Sugar binding induces an outward facing conformation of LacY. Proc. Natl Acad. Sci. USA 104, 16504-16509 (2007).
102. Zhou Y, Guan L, Freites JA, Kaback HR. Opening and closing of the periplasmic gate in lactose permease. Proc. Natl Acad. Sci. USA 105, 3774-3778 (2008).
103. Sigal N, Molshanski-Mor S, Bibi E: No single irreplaceable acidic residues in the Escherichia coli secondary multidrug transporter MdfA. J. Bacteriol. 188, 5635-5639 (2006).
104. Bapna A, Federici L, Venter H et al.: Two proton translocation pathways in a secondary active multidrug transporter. J. Mol. Microbiol. Biotechnol. 12, 197-209 (2007).
105. Schuldiner S: EmrE, a model for studying evolution and mechanism of ion-coupled transporters. Biochim. Biophys. Acta 1794, 748-762 (2009).
106. Elkins CA, Mullis LB: Mammalian steroid hormones are substrates for the major RND- and MFS-type tripartite multidrug efflux pumps of Escherichia coli. J. Bacteriol. 1881, 1191-1195 (2006).
107. Brown MH, Skurray RA: Staphylococcal multidrug efflux protein QacA. J. Mol. Microbiol. Biotechnol. 3, 163-170 (2001).
108. Mitchell BA, Paulsen IT, Brown MH, Skurray RA: Bioenergetics of the staphylococcal multidrug export protein QacA. Identification of distinct binding sites for monovalent and divalent cations. J. Biol. Chem. 274, 3541-3548 (1999).
109. Guan L, Kaback HR: Lessons from lactose permease. Annu. Rev. Biophys. Biomol. Struct. 35, 67-91 (2006).
110. Sigal N, Lewinson O, Wolf SG, Bibi E: E. coli multidrug transporter MdfA is a monomer. Biochemistry 46, 5200-5208 (2007).
111. Tanabe M, Szakonyi G, Brown KA et al.: The multidrug resistance efflux complex, EmrAB from Escherichia coli forms a dimer in vitro. Biochem. Biophys. Res. Commun. 380, 338-342 (2009).